Onat, O. E. Et Al. 2006. MDM2 T309G polymorphism is associated with bladder cancer. 31st Congress of the Federation-of-European-Biochemical-Societies (FEBS) , (İstanbul, Turkey), 225-226.

Onat, O. E., Tez, M., Ozcelik, T., & Toruner, G. A., (2006). MDM2 T309G polymorphism is associated with bladder cancer . 31st Congress of the Federation-of-European-Biochemical-Societies (FEBS) (pp.225-226). İstanbul, Turkey

Onat, ONUR Et Al. "MDM2 T309G polymorphism is associated with bladder cancer," 31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 2006

Onat, ONUR E. Et Al. "MDM2 T309G polymorphism is associated with bladder cancer." 31st Congress of the Federation-of-European-Biochemical-Societies (FEBS) , İstanbul, Turkey, pp.225-226, 2006

Onat, O. E. Et Al. (2006) . "MDM2 T309G polymorphism is associated with bladder cancer." 31st Congress of the Federation-of-European-Biochemical-Societies (FEBS) , İstanbul, Turkey, pp.225-226.

@conferencepaper{conferencepaper, author={ONUR EMRE ONAT Et Al. }, title={MDM2 T309G polymorphism is associated with bladder cancer}, congress name={31st Congress of the Federation-of-European-Biochemical-Societies (FEBS)}, city={İstanbul}, country={Turkey}, year={2006}, pages={225-226} }